Literature DB >> 4369079

Properties of Clostridium perfringens (welchii) type-A alpha-toxin (phospholipase C) purified by electrofocusing.

C J Smyth, J P Arbuthnott.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4369079     DOI: 10.1099/00222615-7-1-41

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


× No keyword cloud information.
  7 in total

1.  Epitope mapping of the alpha-toxin of Clostridium perfringens.

Authors:  A J Logan; E D Williamson; R W Titball; D A Percival; A D Shuttleworth; J W Conlan; D C Kelly
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

2.  Purification of beta-toxin from Clostridium perfringens type C.

Authors:  J Sakurai; C L Duncan
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

Review 3.  Bacterial phospholipases C.

Authors:  R W Titball
Journal:  Microbiol Rev       Date:  1993-06

4.  Enzyme treatment of unfixed cell cultures as a means of determining different specificities of immunoglobulin-M in multiple sclerosis and measles.

Authors:  K B Fraser; P V Shirodaria; M Haire
Journal:  Med Microbiol Immunol       Date:  1974       Impact factor: 3.402

5.  Cloning and expression of the phospholipase C gene from Clostridium perfringens and Clostridium bifermentans.

Authors:  J Y Tso; C Siebel
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

6.  Molecular cloning and nucleotide sequence of the alpha-toxin (phospholipase C) of Clostridium perfringens.

Authors:  R W Titball; S E Hunter; K L Martin; B C Morris; A D Shuttleworth; T Rubidge; D W Anderson; D C Kelly
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

7.  Excitatory effect of Clostridium perfringens alpha toxin on the rat isolated aorta.

Authors:  Y Fujii; S Nomura; Y Oshita; J Sakurai
Journal:  Br J Pharmacol       Date:  1986-07       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.